BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26004674)

  • 21. Sarcoma of the cervix: natural history and outcomes.
    Bansal S; Lewin SN; Burke WM; Deutsch I; Sun X; Herzog TJ; Wright JD
    Gynecol Oncol; 2010 Aug; 118(2):134-8. PubMed ID: 20541244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study.
    Lei J; Andrae B; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Wang J; Fang F; Dillner J; Elfström KM; Sparén P
    BMJ; 2019 Apr; 365():l1207. PubMed ID: 30944091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
    Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
    Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and treatment of invasive cervical cancer in Cambodia (apropos of 35 cases)].
    Monchy D; Lieng CR; Kruy LS; Kahler K; Eav S
    Bull Soc Pathol Exot; 2005 Sep; 98(3):183-6. PubMed ID: 16267957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cervical cancer in the young woman].
    Marie G; Barjot P; Crouet H; Mace-Lesech J; Dommesent D; Uzan M
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):743-7. PubMed ID: 8308200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991.
    Levi F; La Vecchia C; Randimbison L; Te VC
    Ann Oncol; 1994 Oct; 5(8):747-52. PubMed ID: 7826908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elderly women above screening age diagnosed with cervical cancer have a worse prognosis.
    Darlin L; Borgfeldt C; Widén E; Kannisto P
    Anticancer Res; 2014 Sep; 34(9):5147-51. PubMed ID: 25202106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among Tunisian women.
    Missaoui N; Trabelsi A; Landolsi H; Jaidaine L; Mokni M; Korbi S; Hmissa S
    Asian Pac J Cancer Prev; 2010; 11(3):777-80. PubMed ID: 21039053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study.
    Jun JK; Choi KS; Jung KW; Lee HY; Gapstur SM; Park EC; Yoo KY
    Int J Cancer; 2009 Jan; 124(1):188-93. PubMed ID: 18785204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer in men in Cote d'Or (France): epidemiological characteristics, treatments and prognostic factors.
    Dabakuyo TS; Dialla O; Gentil J; Poillot ML; Roignot P; Cuisenier J; Arveux P
    Eur J Cancer Care (Engl); 2012 Nov; 21(6):809-16. PubMed ID: 22642448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.
    Smith HO; Tiffany MF; Qualls CR; Key CR
    Gynecol Oncol; 2000 Aug; 78(2):97-105. PubMed ID: 10926787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in cervical cancer incidence following the introduction of organized screening in Italy.
    Serraino D; Gini A; Taborelli M; Ronco G; Giorgi-Rossi P; Zappa M; Crocetti E; Franzo A; Falcini F; Visioli CB; Stracci F; Zorzi M; Federico M; Michiara M; Fusco M; Ferretti S; Pannozzo F; Tisano F; Zanetti R; Zucchetto A; ;
    Prev Med; 2015 Jun; 75():56-63. PubMed ID: 25818232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association.
    Biron VL; Côté DW; Seikaly H
    J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S65-9. PubMed ID: 21453664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of tumor diameter on treatment results in cervical cancer patients].
    Jońska-Gmyrek J; Zółciak-Siwińska A; Gmyrek L; Staniaszek J; Lindner B; Andrzejuk J
    Ginekol Pol; 2012 Aug; 83(8):576-80. PubMed ID: 23342879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of subsequent abnormal cytology in cervical cancer patients completing five-years of post treatment surveillance without evidence of recurrence.
    Orr JM; Barnett JC; Leath CA
    Gynecol Oncol; 2011 Sep; 122(3):501-4. PubMed ID: 21714992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population-based survey of the management of women with cancer of the cervix.
    Clarke F; Dey P; Collins S
    Br J Cancer; 1999 Aug; 80(12):1958-61. PubMed ID: 10471045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening history in women with cervical cancer in a Danish population-based screening program.
    Kirschner B; Poll S; Rygaard C; Wåhlin A; Junge J
    Gynecol Oncol; 2011 Jan; 120(1):68-72. PubMed ID: 21035171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
    Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based organized cervical cancer screening pilot program in France.
    Hamers FF; Duport N; Beltzer N
    Eur J Cancer Prev; 2018 Sep; 27(5):486-492. PubMed ID: 28362653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.